Authors/Disclosures
|
Keith R. Edwards, MD, FAAN
(MS Center of Northeastern New York)
|
No disclosure on file |
|
Lori H. Travis, MD
|
No disclosure on file |
|
Annette Okai, MD, FAAN
(North Texas Institute of Neurology and Headache)
|
Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics. |
|
|
No disclosure on file |
|
Francisco J. Gomez, MD
|
No disclosure on file |
|
Lisa E. Farnett, PharmD
(Sanofi)
|
Ms. Farnett has received personal compensation for serving as an employee of Sanofi. Ms. Farnett has stock in Sanofi. |
|
Steven J. Cavalier, MD, FAAN
(SC Consulting)
|
No disclosure on file |
|
Darren M. Stam, PharmD
(Genzyme, A Sanofi Company)
|
No disclosure on file |
|
Ken Liu
|
No disclosure on file |